Marina Ripamonti

Preclinical evaluation of polymer-bound doxorubicin

Ruth Duncan, Leonard W. Seymour, K.B. O'Hare et al. · Journal of Controlled Release · 1992 · 188 citations

Engineering, Polymer-drug Conjugate, Polymer Science +3

The Active Centres of Agelastatin A, a Strongly Cytotoxic Alkaloid of the Coral Sea Axinellid Sponge <i>Agelas dendromorpha</i>, as Determined by Comparative Bioassays with Semisynthetic Derivatives

Michele D’Ambrosio, Antonio Guerriero, Francesco Pietra et al. · Helvetica Chimica Acta · 1996 · 82 citations

Bioorganic Chemistry, Engineering, Marine Chemistry +17

In vivo anti-tumour activity of FCE 23762, a methoxymorpholinyl derivative of doxorubicin active on doxorubicin-resistant tumour cells

Marina Ripamonti, Gabriella Pezzoni, Enrico Pesenti et al. · British Journal of Cancer · 1992 · 48 citations · Full text

Tumor Biology, Medicinal Chemistry, Drug Targeting +11

Ricin A Chain Conjugated With Monoclonal Antibodies Selectively Killing Human Carcinoma Cells In Vitro2

Silvana Canevari, Rosaria Orlandi, Marina Ripamonti et al. · JNCI Journal of the National Cancer Institute · 1985 · 38 citations

Tumor Biology, Oncology, Chain Conjugated +14

The <i>Aspergillus</i> toxin restrictocin is a suitable cytotoxic agent for generation of immunoconjugates with monoclonal antibodies directed against human carcinoma cells

Francisco P. Conde, Rosaria Orlandi, Silvana Canevari et al. · European Journal of Biochemistry · 1989 · 37 citations · Full text